Literature DB >> 18923772

Osteomyelitis management: More art than science?

Bl Johnston1, Jm Conly.   

Abstract

Entities:  

Year:  2007        PMID: 18923772      PMCID: PMC2533541          DOI: 10.1155/2007/968523

Source DB:  PubMed          Journal:  Can J Infect Dis Med Microbiol        ISSN: 1712-9532            Impact factor:   2.471


× No keyword cloud information.
  36 in total

1.  Ofloxacin versus parenteral therapy for chronic osteomyelitis.

Authors:  L O Gentry; G Rodriguez-Gomez
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

2.  Culture of percutaneous bone biopsy specimens for diagnosis of diabetic foot osteomyelitis: concordance with ulcer swab cultures.

Authors:  Eric Senneville; Hugues Melliez; Eric Beltrand; Laurence Legout; Michel Valette; Marie Cazaubiel; Muriel Cordonnier; Michèle Caillaux; Yazdan Yazdanpanah; Yves Mouton
Journal:  Clin Infect Dis       Date:  2005-11-21       Impact factor: 9.079

Review 3.  Osteomyelitis.

Authors:  D P Lew; F A Waldvogel
Journal:  N Engl J Med       Date:  1997-04-03       Impact factor: 91.245

4.  Diabetic foot infections. Bacteriologic analysis.

Authors:  L J Wheat; S D Allen; M Henry; C B Kernek; J A Siders; T Kuebler; N Fineberg; J Norton
Journal:  Arch Intern Med       Date:  1986-10

Review 5.  Management of bone and joint infections due to Staphylococcus aureus.

Authors:  J S Davis
Journal:  Intern Med J       Date:  2005-12       Impact factor: 2.048

6.  Penetration of methicillin, oxacillin, and cephalothin into bone and synovial tissues.

Authors:  R H Fitzgerald; P J Kelly; R J Snyder; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1978-11       Impact factor: 5.191

7.  Etiologic diagnosis of chronic osteomyelitis: a prospective study.

Authors:  Andres F Zuluaga; Wilson Galvis; Juan G Saldarriaga; Maria Agudelo; Beatriz E Salazar; Omar Vesga
Journal:  Arch Intern Med       Date:  2006-01-09

8.  Chronic osteomyelitis caused by Staphylococcus aureus: controlled clinical trial of nafcillin therapy and nafcillin-rifampin therapy.

Authors:  C W Norden; R Bryant; D Palmer; J Z Montgomerie; J Wheat
Journal:  South Med J       Date:  1986-08       Impact factor: 0.954

9.  Foot infections in diabetic patients. Decision and cost-effectiveness analyses.

Authors:  M H Eckman; S Greenfield; W C Mackey; J B Wong; S Kaplan; L Sullivan; K Dukes; S G Pauker
Journal:  JAMA       Date:  1995-03-01       Impact factor: 56.272

10.  Concentration of clindamycin in human bone.

Authors:  P Nicholas; B R Meyers; R N Levy; S Z Hirschman
Journal:  Antimicrob Agents Chemother       Date:  1975-08       Impact factor: 5.191

View more
  3 in total

Review 1.  Staphylococcal Osteomyelitis: Disease Progression, Treatment Challenges, and Future Directions.

Authors:  Nicola Kavanagh; Emily J Ryan; Amro Widaa; Gillian Sexton; Jerome Fennell; Sadhbh O'Rourke; Kevin C Cahill; Cathal J Kearney; Fergal J O'Brien; Steven W Kerrigan
Journal:  Clin Microbiol Rev       Date:  2018-02-14       Impact factor: 26.132

Review 2.  Management of osteomyelitis of the foot in diabetes mellitus.

Authors:  Fran Game
Journal:  Nat Rev Endocrinol       Date:  2010-01       Impact factor: 43.330

3.  Making the equivocal unequivocal: standardization of clean margins in diabetic foot osteomyelitis.

Authors:  Brian M Schmidt; Christine Jarocki
Journal:  Clin Diabetes Endocrinol       Date:  2020-05-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.